AKTX Akari Therapeutics, Plc

Fundamentals / CIK 0001541157 / USD

Akari Therapeutics, Plc reported $36.58M in total assets and a net loss of $29.40M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AKTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$33.10MFY 2016 Net Income: -$18.14M2016FY 2017 Net Income: -$35.40M2017FY 2018 Net Income: -$20.50M2018FY 2019 Net Income: -$16.85M2019FY 2020 Net Income: -$17.08M2020FY 2021 Net Income: -$17.42M2021FY 2022 Net Income: -$17.75M2022FY 2023 Net Income: -$10.01M2023FY 2024 Net Income: -$19.79M2024FY 2025 Net Income: -$17.30M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $2.81M $6.98M $5.45M $9.56M $9.13M $8.82M $8.74M $11.80M $23.29M $17.31M
Selling, General & Admin $9.28M $9.66M $11.36M $13.53M $8.08M $9.16M $8.22M $11.69M $11.80M $9.94M
Total Operating Expenses $17.27M $21.64M $16.81M $23.09M $17.21M $17.98M $16.96M $20.79M $37.78M $27.25M
Operating Income -$17.27M -$21.64M -$16.81M -$23.09M -$17.21M -$17.98M -$16.96M -$20.79M -$37.78M -$27.25M
EBITDA -- -$21.63M -$16.80M -$23.08M -$17.21M -$17.97M -$16.94M -$20.75M -$37.74M -$27.21M
Interest Income $1.0K $8.0K $82K $46K $11K $14K $5.5K $222K $175K $143K
Interest Expense $100K $244K -- -- -- -- -- -- $0 $0
Income Before Tax -$18.30M -$19.79M -$10.01M -$18K -$17.42M -$17.08M -$16.85M -$20.50M -$35.40M -$18.14M
Income Tax Expense -$1.00M $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$17.30M -$19.79M -$10.01M -$17.75M -$17.42M -$17.08M -$16.85M -$20.50M -$35.40M -$18.14M
Basic EPS $0.00 $0.00 $0.00 $0.00 $0.00 -$0.01 -$0.01 -$0.01 -$0.03 -$0.02
Diluted EPS $0.00 $0.00 $0.00 $0.00 $0.00 -$0.01 -$0.01 -$0.01 -$0.03 -$0.02
Basic Shares Outstanding 67.33B 23.89B 9.79B 6.24B 4.29B 3.16B 1.83B 1.54B 1.25B 1.18B
Diluted Shares Outstanding 67.33B 23.89B 9.79B 6.24B 4.29B 3.16B 1.83B 1.54B 1.25B 1.18B

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $2.11M $2.08M $1.46M $1.09M $249K $667K $813K $1.25M
Selling, General & Admin $2.57M $2.52M $2.17M $2.14M $1.98M $2.45M $2.71M $3.05M
Total Operating Expenses -- -- $15.76M -- -- -- $3.52M --
Operating Income -$4.68M -$4.60M -$15.76M -$3.23M -$7.40M -$3.12M -$3.52M -$5.28M
EBITDA -- -- -- -- -- -- -- -$5.28M
Interest Income -- -- -- -- $1.0K -- -- $1.0K
Interest Expense $85K $80K $61K $723K $100K $50K $55K --
Income Before Tax -$4.84M -$4.81M -$15.31M -$5.21M -$7.49M -$1.90M -$3.71M --
Income Tax Expense $0 $0 -$859K $85K -$1.09M $0 $0 --
Net Income -$4.84M -$4.81M -$14.46M -$5.30M -$6.40M -$1.90M -$3.71M -$3.77M
Basic EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00 --
Diluted EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00 --
Basic Shares Outstanding 265.89B 143.32B 118.76B -- 65.33B 62.94B 54.59B --
Diluted Shares Outstanding 265.89B 143.32B 118.76B -- 65.33B 62.94B 54.59B --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Sep 30 Jun 30 Mar 31 Dec 31
Cash & Cash Equivalents $5.20M $0 $3.85M $13.25M $9.36M $14.06M $12.32M $12.75M $7.82M $5.73M
Cash & Short-Term Investments $5.20M $0 $3.85M $13.25M $9.36M $14.06M $12.32M $12.75M $7.82M $5.73M
Other Current Assets $14K $201K $197K $100K $90K $229K -- -- -- --
Total Current Assets $5.46M $2.95M $4.34M $13.81M $11.63M $14.58M $13.67M $14.43M $9.65M $6.44M
Property, Plant & Equipment, Net -- -- -- $0 $0 $0 -- -- $2.1K $5.0K
Goodwill $8.43M $8.43M -- -- -- -- -- -- -- --
Intangible Assets -- -- $14K $17K $23K $27K $27K $26K $28K $30K
Total Non-Current Assets $42.43M $47.61M $14K $17K $23K $27K $27K $26K $30K $35K
Total Assets $47.89M $50.56M $4.36M $13.83M $11.65M $14.60M $13.69M $14.45M $9.68M $6.48M
Accounts Payable $8.77M $12.41M $1.67M $947K $1.79M $3.38M $2.41M $2.19M $966K $1.23M
Other Current Liabilities $424K $94K $94K $94K $0 -- -- -- -- --
Total Current Liabilities $12.35M $19.91M $4.58M -- -- -- -- -- -- --
Other Non-Current Liabilities $31K $383K -- -- -- -- -- -- -- --
Total Non-Current Liabilities $7.21M $8.42M $0 -- -- -- -- -- -- --
Total Liabilities $19.56M $28.33M $4.58M $12.04M $6.09M $5.22M $6.75M $8.49M $6.41M $6.47M
Common Stock -- $5.32M $1.32M $745K $476K $385K $46.58M $46.58M $40.09M $31.99M
Retained Earnings -$264.6M -$247.3M -$227.5M -$217.5M -$199.7M -$182.3M -$175.5M -$176.4M -$168.9M -$165.2M
Accumulated Other Comp. Income -$782K -$738K -$1.04M -$771K -$541K -$648K -$621K -$618K -$572K -$349K
Total Stockholders' Equity $28.33M $22.23M -$229K $1.79M $5.55M $9.38M $6.95M $5.96M $3.27M $7.6K
Total Equity $28.33M $22.23M -$229K $1.79M $5.55M $9.38M $6.95M $5.96M $3.27M $7.6K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $5.74M $7.69M $2.77M $5.20M $2.48M $2.71M $2.58M $0
Cash & Short-Term Investments $5.74M $7.69M $2.77M $5.20M $2.48M $2.71M $2.58M $0
Other Current Assets $107K $38K $30K $14K $53K $83K $80K $201K
Total Current Assets $6.28M $8.32M $3.59M $5.46M $2.95M $3.30M $3.35M $2.95M
Goodwill -- -- -- $8.43M $8.43M $8.43M $8.43M $8.43M
Total Non-Current Assets $30.30M $30.30M $30.30M $42.43M $42.43M $47.61M $47.61M $47.61M
Total Assets $36.58M $38.62M $33.89M $47.89M $45.38M $50.91M $50.96M $50.56M
Accounts Payable $9.05M $9.40M $8.64M $8.77M $10.84M $11.61M $13.07M $12.41M
Other Current Liabilities $54K $212K $697K $424K $481K $650K $484K $94K
Total Current Liabilities $12.98M $13.94M $13.41M $12.35M $15.57M $17.14M $20.91M $19.91M
Other Non-Current Liabilities -- -- -- $31K $69K $128K $266K $383K
Total Non-Current Liabilities $6.09M $6.09M $6.09M $7.21M $7.12M $8.17M $8.31M $8.42M
Total Liabilities $19.08M $20.03M $19.51M $19.56M $22.69M $25.31M $29.21M $28.33M
Common Stock $1.0K $1.0K -- -- $6.52M $6.52M $5.78M $5.32M
Retained Earnings -$288.7M -$283.8M -$279.0M -$264.6M -$259.3M -$252.9M -$251.0M -$247.3M
Accumulated Other Comp. Income -$614K -$695K -$768K -$782K -$1.14M -$1.11M -$773K -$738K
Total Stockholders' Equity $17.50M $18.59M $14.38M $28.33M $22.69M $25.61M $21.75M $22.23M
Total Equity $17.50M $18.59M $14.38M $28.33M $22.69M $25.61M $21.75M $22.23M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$17.30M -$19.79M -$10.01M -$17.75M -$17.42M -$17.08M -$16.85M -$20.50M -$35.40M -$18.14M
Depreciation & Amortization -- $14K $4.0K $4.0K $4.1K $8.9K $19K $36K $42K $40K
Stock-Based Compensation $2.89M $2.25M $1.15M $735K $315K $326K $1.05M $1.65M $2.73M $3.93M
Operating Cash Flow -$10.57M -$12.55M -$16.43M -$21.50M -$18.85M -$16.95M -$12.92M -$22.77M -$31.60M -$24.62M
Capital Expenditure -- -- -- -- -- -- $0 $0 -$37K -$55K
Free Cash Flow -- -- -- -- -- -- -$12.92M -$22.77M -$31.64M -$24.68M
Investing Cash Flow -- $382K -- -- -- -- $0 $0 $9.99M -$10.07M
Common Stock Issued $10.72M $11.81M $7.02M $25.19M $14.29M $25.05M $12.65M $500K $15.67M $0
Financing Cash Flow $13.17M $10.99M $7.02M $25.29M $14.29M $25.07M $12.65M $500K $15.67M $0
Net Change in Cash $2.60M -$1.19M -$9.40M $3.89M -$4.69M $8.32M -$236K -$22.28M -$5.99M -$34.82M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$4.84M -$4.81M -$14.46M -$5.30M -$6.40M -$1.90M -$3.71M -$3.77M
Depreciation & Amortization -- -- -- -- -- -- -- $1.0K
Stock-Based Compensation $537K $711K $305K $471K $685K $719K $1.01M $1.26M
Operating Cash Flow -$4.22M -$3.11M -$2.49M -$3.04M -$2.12M -$3.26M -$2.15M -$2.12M
Common Stock Issued -- -- -- $4.85M $0 $4.79M $1.09M $3.13M
Financing Cash Flow $2.27M $8.04M $53K $5.76M $1.90M $3.38M $2.13M $2.15M
Net Change in Cash -$1.95M $4.93M -$2.44M $2.72M -$227K $129K -$17K $413K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -61.1% -89.0% -- -991.0% -313.7% -182.0% -221718.9% -469.2% -159.2% -53.2%
Return on Assets (ROA) -36.1% -39.1% -229.8% -128.3% -149.6% -117.0% -260.0% -255.3% -121.9% -39.5%
Current Ratio 0.44x 0.15x 0.95x -- -- -- -- 1.52x 2.43x 3.90x
Quick Ratio 0.42x 0.00x 0.84x -- -- -- -- 1.11x 2.37x 3.77x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -168.0% -166.5% -195.0% -61.1% -69.5% -47.9% -82.5% -89.0%
Return on Assets (ROA) -80.4% -80.2% -82.8% -36.1% -34.8% -24.1% -35.2% -39.1%
Current Ratio 0.48x 0.60x 0.27x 0.44x 0.19x 0.19x 0.16x 0.15x
Quick Ratio 0.44x 0.55x 0.21x 0.42x 0.16x 0.16x 0.12x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001541157) · from December 31, 2006 Data through September 30, 2026 · synced Nov 21, 2026, 05:04 UTC · Open in terminal